Patent · US Active

Engineered imine reductases and methods for the reductive amination of ketone and amine compounds

US9828614B1 · kind B1 · utility

10Cited by
7References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 2017
Grant dateNov 28, 2017
Priority date
Expiry dateSep 20, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/52
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides engineered polypeptides having imine reductase activity, polynucleotides encoding the engineered imine reductases, host cells capable of expressing the engineered imine reductases, and methods of using these engineered polypeptides with a range of ketone and amine substrate compounds to prepare secondary and tertiary amine product compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.